Downregulated CXCL12 expression in mesenchymal stem cells associated with severe aplastic anemia in children

Annals of Hematology

Volumn 94, Issue 1, 2015, Pages 13-22

  Chao, Yu Hua ^a,b   Wu, Kang Hsi ^c,d   Chiou, Shiow Her ^e   Chiang, Shu Fen ^e   Huang, Chih Yang ^e   Yang, Hsiu Ching ^e   Chan, Chin Kan ^f   Peng, Ching Tien ^c,d,g   Wu, Han Ping ^h   Chow, Kuan Chih ^e   Lee, Maw Sheng ^a,b  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^f TAO YUAN GENERAL HOSPITAL   (Taiwan)

^g ASIA UNIVERSITY   (Taiwan)

^h BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

Aplastic anemia; Bone marrow failure; CXCL12; Gene expression; Mesenchymal stem cells

Indexed keywords

CXCL12 PROTEIN, HUMAN; STROMAL CELL DERIVED FACTOR 1;

ADOLESCENT; ANEMIA, APLASTIC; BIOSYNTHESIS; CHILD; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; MALE; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY; PRESCHOOL CHILD; PROCEDURES; SEVERITY OF ILLNESS INDEX;

ADOLESCENT; ANEMIA, APLASTIC; CHEMOKINE CXCL12; CHILD; CHILD, PRESCHOOL; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; SEVERITY OF ILLNESS INDEX;

EID: 84925287349     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-014-2159-0     Document Type: Article

References (44)

1. Montane E, Ibanez L, Vidal X, Ballarin E, Puig R, Garcia N, Laporte J-R, Catalan Group for Study of Agranulocytosis and Aplastic Anemia (2008) Epidemiology of aplastic anemia: a prospective multicenter study. Haematologica 93:518–523
2. Davies JK, Guinan EC (2007) An update on the management of severe idiopathic aplastic anaemia in children. Br J Haematol 136:549–564
3. Kurre P, Johnson FL, Deeg HJ (2005) Diagnosis and treatment of children with aplastic anemia. Pediatr Blood Cancer 45:770–780
4. Lazennec G, Jorgensen C (2008) Concise review: adult multipotent stromal cells and cancer: risk or benefit? Stem Cells 26:1387–1394
5. Sorrentino A, Ferracin M, Castelli G, Biffoni M, Tomaselli G, Baiocchi M, Fatica A, Negrini M, Peschle C, Valtieri M (2008) Isolation and characterization of CD146+ multipotent mesenchymal stromal cells. Exp Hematol 36:1035–1046
6. Deans RJ, Moseley AB (2000) Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 28:875–884
7. Verfaillie CM (1993) Soluble factor(s) produced by human bone marrow stroma increase cytokine-induced proliferation and maturation of primitive hematopoietic progenitors while preventing their terminal differentiation. Blood 82:2045–2053
8. Gordon MY (1988) Extracellular matrix of the marrow microenvironment. Br J Haematol 70:1–4
9. Chao YH, Wu HP, Chan CK, Tsai C, Peng CT, Wu KH (2012) Umbilical cord-derived mesenchymal stem cells for hematopoietic stem cell transplantation. J Biomed Biotechnol 2012:759503
10. Wu KH, Sheu JN, Wu HP, Tsai C, Sieber M, Peng CT, Chao YH (2013) Cotransplantation of umbilical cord-derived mesenchymal stem cells promote hematopoietic engraftment in cord blood transplantation: a pilot study. Transplantation 95:773–777
11. Xu Y, Takahashi Y, Wang Y, Hama A, Nishio N, Muramatsu H, Tanaka M, Yoshida N, Villalobos IB, Yagasaki H, Kojima S, Xu Y, Takahashi Y, Wang Y, Hama A, Nishio N, Muramatsu H, Tanaka M, Yoshida N, Villalobos IB, Yagasaki H, Kojima S (2009) Downregulation of GATA-2 and overexpression of adipogenic gene-PPARgamma in mesenchymal stem cells from patients with aplastic anemia. Exp Hematol 37:1393–1399
12. Holmberg LA, Seidel K, Leisenring W, Torok-Storb B (1994) Aplastic anemia: analysis of stromal cell function in long-term marrow cultures. Blood 84:3685–3690
13. Bacigalupo A, Valle M, Podesta M, Pitto A, Zocchi E, De Flora A, Pozzi S, Luchetti S, Frassoni F, Van Lint MT, Piaggio G (2005) T-cell suppression mediated by mesenchymal stem cells is deficient in patients with severe aplastic anemia. Exp Hematol 33:819–827
14. Hotta T, Kato T, Maeda H, Yamao H, Yamada H, Saito H (1985) Functional changes in marrow stromal cells in aplastic anaemia. Acta Haematol 74:65–69
15. Wu X, Li Y, Zhu K, Wang Z, Chen S, Yang L (2007) GATA-1, −2 and −3 genes expression in bone marrow microenviroment with chronic aplastic anemia. Hematology 12:331–335
16. Li J, Yang S, Lu S, Zhao H, Feng J, Li W, Ma F, Ren Q, Liu B, Zhang L, Zheng Y, Han ZC (2012) Differential gene expression profile associated with the abnormality of bone marrow mesenchymal stem cells in aplastic anemia. PLoS ONE 7:e47764
17. Chao YH, Tsai C, Peng CT, Wu HP, Chan CK, Weng T, Wu KH (2011) Cotransplantation of umbilical cord MSCs to enhance engraftment of hematopoietic stem cells in patients with severe aplastic anemia. Bone Marrow Transplant 46:1391–1392
18. Chao YH, Peng CT, Harn HJ, Chan CK, Wu KH (2010) Poor potential of proliferation and differentiation in bone marrow mesenchymal stem cells derived from children with severe aplastic anemia. Ann Hematol 89:715–723
19. Chan CK, Wu KH, Lee YS, Hwang SM, Lee MS, Liao SK, Cheng EH, See LC, Tsai CN, Kuo ML, Huang JL (2012) The comparison of interleukin 6-associated immunosuppressive effects of human ESCs, fetal-type MSCs, and adult-type MSCs. Transplantation 94:132–138
20. Wu KH, Chan CK, Tsai C, Chang YH, Sieber M, Chiu TH, Ho M, Peng CT, Wu HP, Huang JL (2011) Effective treatment of severe steroid-resistant acute graft-versus-host disease with umbilical cord-derived mesenchymal stem cells. Transplantation 91:1412–1416
21. Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringden O (2003) Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 57:11–20
22. Sturn A, Quackenbush J, Trajanoski Z (2002) Genesis: cluster analysis of microarray data. Bioinformatics 18:207–208
23. Harris MA, Clark J, Ireland A et al (2004) The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res 32:D258–D261
24. Sutton JF, Stacey M, Kearns WG, Rieg TS, Young NS, Liu JM (2004) Increased risk for aplastic anemia and myelodysplastic syndrome in individuals lacking glutathione S-transferase genes. Pediatr Blood Cancer 42:122–126
25. Fuhrer M, Durner J, Brunnler G, Gotte H, Deppner C, Bender-Gotze C, Albert E (2007) HLA association is different in children and adults with severe acquired aplastic anemia. Pediatr Blood Cancer 48:186–191
26. Watt SM, Forde SP (2008) The central role of the chemokine receptor, CXCR4, in haemopoietic stem cell transplantation: will CXCR4 antagonists contribute to the treatment of blood disorders? Vox Sang 94:18–32
27. Mishima S, Nagai A, Abdullah S, Matsuda C, Taketani T, Kumakura S, Shibata H, Ishikura H, Kim SU, Masuda J (2010) Effective ex vivo expansion of hematopoietic stem cells using osteoblast-differentiated mesenchymal stem cells is CXCL12 dependent. Eur J Haematol 84:538–546
28. Nie Y, Han YC, Zou YR (2008) CXCR4 is required for the quiescence of primitive hematopoietic cells. J Exp Med 205:777–783
29. Lataillade JJ, Clay D, Bourin P, Herodin F, Dupuy C, Jasmin C, Le Bousse-Kerdiles MC (2002) Stromal cell-derived factor 1 regulates primitive hematopoiesis by suppressing apoptosis and by promoting G(0)/G(1) transition in CD34(+) cells: evidence for an autocrine/paracrine mechanism. Blood 99:1117–1129
30. Broxmeyer HE, Kohli L, Kim CH, Lee Y, Mantel C, Cooper S, Hangoc G, Shaheen M, Li X, Clapp DW (2003) Stromal cell-derived factor-1/CXCL12 directly enhances survival/antiapoptosis of myeloid progenitor cells through CXCR4 and G(alpha)i proteins and enhances engraftment of competitive, repopulating stem cells. J Leukocyte Biol 73:630–638
31. Tzeng YS, Li H, Kang YL, Chen WC, Cheng WC, Lai DM (2011) Loss of Cxcl12/Sdf-1 in adult mice decreases the quiescent state of hematopoietic stem/progenitor cells and alters the pattern of hematopoietic regeneration after myelosuppression. Blood 117:429–439
32. Nagasawa T, Hirota S, Tachibana K, Takakura N, Nishikawa S, Kitamura Y, Yoshida N, Kikutani H, Kishimoto T (1996) Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382:635–638
33. Ma Q, Jones D, Borghesani PR, Segal RA, Nagasawa T, Kishimoto T, Bronson RT, Springer TA (1998) Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci U S A 95:9448–9453
34. Sugiyama T, Kohara H, Noda M, Nagasawa T (2006) Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 25:977–988
35. Kiel MJ, Morrison SJ (2006) Maintaining hematopoietic stem cells in the vascular niche. Immunity 25:862–864
36. Semerad CL, Christopher MJ, Liu F, Short B, Simmons PJ, Winkler I, Levesque JP, Chappel J, Ross FP, Link DC (2005) G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. Blood 106:3020–3027
37. Petit I, Szyper-Kravitz M, Nagler A, Lahav M, Peled A, Habler L, Ponomaryov T, Taichman RS, Arenzana-Seisdedos F, Fujii N, Sandbank J, Zipori D, Lapidot T (2002) G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 3:687–694
38. Mendez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, Lira SA, Scadden DT, Ma'ayan A, Enikolopov GN, Frenette PS (2010) Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466:829–834
39. Schajnovitz A, Itkin T, D'Uva G, Kalinkovich A, Golan K, Ludin A, Cohen D, Shulman Z, Avigdor A, Nagler A, Kollet O, Seger R, Lapidot T (2011) CXCL12 secretion by bone marrow stromal cells is dependent on cell contact and mediated by connexin-43 and connexin-45 gap junctions. Nat Immunol 12:391–398
40. Marquez-Curtis LA, Janowska-Wieczorek A (2013) Enhancing the migration ability of mesenchymal stromal cells by targeting the SDF-1/CXCR4 axis. BioMed Res Int 2013:561098
41. Bobis-Wozowicz S, Miekus K, Wybieralska E, Jarocha D, Zawisz A, Madeja Z, Majka M (2011) Genetically modified adipose tissue-derived mesenchymal stem cells overexpressing CXCR4 display increased motility, invasiveness, and homing to bone marrow of NOD/SCID mice. Exp Hematol 39:686–696
42. Cao Z, Zhang G, Wang F, Liu H, Liu L, Han Y, Zhang J, Yuan J (2013) Protective effects of mesenchymal stem cells with CXCR4 up-regulation in a rat renal transplantation model. PLoS ONE 8:e82949
43. Chen W, Li M, Li Z, Yan Z, Cheng H, Pan B, Cao J, Chen C, Zeng L, Xu K (2012) CXCR4-transduced mesenchymal stem cells protect mice against graft-versus-host disease. Immunol Lett 143:161–169
44. Zaim M, Karaman S, Cetin G, Isik S (2012) Donor age and long-term culture affect differentiation and proliferation of human bone marrow mesenchymal stem cells. Ann Hematol 91:1175–1186